| Lillie Edwards Bates, MD | |
|
811 W Main St, Ste 204, Lexington, SC 29072-2507 | |
| (803) 359-8855 | |
| (803) 359-1257 |
| Full Name | Lillie Edwards Bates |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 811 W Main St, Lexington, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487649729 | NPI | - | NPPES |
| 155995 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 15599 (South Carolina) | Primary |
| Entity Name | Lexington Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710634753 PECOS PAC ID: 2567872070 Enrollment ID: O20201208000922 |
News Archive
Queen's University Brian Amsden is hoping that in about 10 years a tendon, spinal cord or heart valve will be able to regenerate itself after an injury or disease. The chemical engineering professor, along with scientists from the University of Western Ontario and University of Toronto, is currently trying to develop microscopic polymer fibers to help rebuild human tissue and speed the healing process.
Health Diagnostic Laboratory, Inc., a leader in disease state management, today announced its new capability to run the CYP2C19 genetic test. HDL, Inc., headquartered in the Virginia Biotechnology Research Park, has added CYP2C19 to its comprehensive panel of tests to help physicians better personalize treatment based on an expanded, total patient profile.
Bright Instruments will exhibit its new OTF5500 Touch Screen for the first time in public next week at the IBMS Congress (28-30 Sept 2015, Stand 800) in Birmingham UK. This is a significant update to the existing OTF 5000.
Generex Biotechnology Corporation announced today publication of results from the first Phase I study of its lead immunotherapeutic agent AE37 in patients with prostate cancer. At the end of 2009, the Company announced positive interim results from a Phase II trial being conducted with AE37 in patients with breast cancer. The compound is being developed by its wholly-owned subsidiary, Antigen Express, Inc.
In response to reports of contaminated milk-based infant formula manufactured in China, the U.S. Food and Drug Administration (FDA) is issuing a Health Information Advisory.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lillie Edwards Bates, MD Po Box 6069, West Columbia, SC 29171-6069 Ph: () - | Lillie Edwards Bates, MD 811 W Main St, Ste 204, Lexington, SC 29072-2507 Ph: (803) 359-8855 |
News Archive
Queen's University Brian Amsden is hoping that in about 10 years a tendon, spinal cord or heart valve will be able to regenerate itself after an injury or disease. The chemical engineering professor, along with scientists from the University of Western Ontario and University of Toronto, is currently trying to develop microscopic polymer fibers to help rebuild human tissue and speed the healing process.
Health Diagnostic Laboratory, Inc., a leader in disease state management, today announced its new capability to run the CYP2C19 genetic test. HDL, Inc., headquartered in the Virginia Biotechnology Research Park, has added CYP2C19 to its comprehensive panel of tests to help physicians better personalize treatment based on an expanded, total patient profile.
Bright Instruments will exhibit its new OTF5500 Touch Screen for the first time in public next week at the IBMS Congress (28-30 Sept 2015, Stand 800) in Birmingham UK. This is a significant update to the existing OTF 5000.
Generex Biotechnology Corporation announced today publication of results from the first Phase I study of its lead immunotherapeutic agent AE37 in patients with prostate cancer. At the end of 2009, the Company announced positive interim results from a Phase II trial being conducted with AE37 in patients with breast cancer. The compound is being developed by its wholly-owned subsidiary, Antigen Express, Inc.
In response to reports of contaminated milk-based infant formula manufactured in China, the U.S. Food and Drug Administration (FDA) is issuing a Health Information Advisory.
› Verified 1 days ago
Dennis A Cohen, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1316 N Lake Dr, Lexington, SC 29072 Phone: 803-808-5050 Fax: 803-808-5059 | |
Amanda Ruscin Vartanian, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 811 W Main St Ste 204, Lexington, SC 29072 Phone: 803-359-8855 Fax: 803-359-1257 | |
Naren S. Shenoy, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1970 Augusta Hwy, Lexington, SC 29072 Phone: 803-358-2370 Fax: 803-358-2376 | |
Dr. James Luther Pruitt Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 448 Old Cherokee Rd, Lexington, SC 29072 Phone: 803-520-9261 Fax: 803-520-9262 | |
Dr. James Brandon Emery, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 811 W Main St, Suite 204, Lexington, SC 29072 Phone: 803-359-8855 | |
Andrew Pittard, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 448 Old Cherokee Rd, Lexington, SC 29072 Phone: 803-520-5800 | |
Daniel Anthony Powers, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1223 S Lake Dr Ste G, Lexington, SC 29073 Phone: 803-520-9370 Fax: 803-520-9371 |